ZimVie Inc. (NASDAQ:ZIMV – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $20.40, but opened at $18.60. ZimVie shares last traded at $18.91, with a volume of 74,912 shares traded.
Wall Street Analysts Forecast Growth
Separately, Needham & Company LLC upped their price objective on shares of ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Friday.
Check Out Our Latest Report on ZimVie
ZimVie Trading Down 13.1 %
ZimVie (NASDAQ:ZIMV – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.13 earnings per share (EPS) for the quarter. The business had revenue of $116.81 million for the quarter. ZimVie had a negative net margin of 56.31% and a positive return on equity of 2.01%. During the same quarter last year, the company earned $0.17 EPS. As a group, equities analysts forecast that ZimVie Inc. will post 0.63 EPS for the current year.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. Cetera Advisors LLC acquired a new stake in shares of ZimVie during the 1st quarter worth approximately $2,615,000. Charles Schwab Investment Management Inc. increased its stake in ZimVie by 21.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 761,285 shares of the company’s stock worth $13,513,000 after purchasing an additional 132,804 shares in the last quarter. First Eagle Investment Management LLC boosted its holdings in shares of ZimVie by 73.1% in the fourth quarter. First Eagle Investment Management LLC now owns 294,673 shares of the company’s stock valued at $5,230,000 after buying an additional 124,487 shares during the period. Russell Investments Group Ltd. raised its stake in shares of ZimVie by 60.4% in the 4th quarter. Russell Investments Group Ltd. now owns 279,413 shares of the company’s stock valued at $4,960,000 after purchasing an additional 105,256 shares during the period. Finally, CenterBook Partners LP acquired a new stake in ZimVie in the 4th quarter valued at approximately $988,000. Institutional investors and hedge funds own 95.63% of the company’s stock.
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Stories
- Five stocks we like better than ZimVie
- Why Are Stock Sectors Important to Successful Investing?
- Should You Invest in Bitcoin? Pros and Cons
- Manufacturing Stocks Investing
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.